| Document |
Document Title |
|
WO/2002/053616A1 |
The present invention relates to a linear polymer with a molecular weight of at least 10?4¿ Dalton, which linear polymer consists of internally and linearly linked sequences, which sequences can be described according to Formula (1) whe...
|
|
WO/2002/053526A1 |
The present invention relates to a compound according to Formula (1) wherein R¿1? and R¿2? which R¿1? and R¿2? can be the same or different, are amino((C¿2?-C¿5?)alkyl), ((C¿1?-C¿4?)alkyl[(2-4)-amino((C¿2?-C¿4?)alkanoate)], or ...
|
|
WO/2002/051461A1 |
An anhydrous, hydrophilic wound dressing containing a superabsorbent polymer and an antimicrobial agent. Its anhydrous nature allows it, when applied to a wound site, to absorb wound fluid and slowly release its water-soluble active micr...
|
|
WO2001013908A9 |
Devices, compositions, and methods for achieving non-surgical lung volume reduction (e.g., bronchoscopic lung volume reduction (BLVR)) are described. BLVR can be carried out by collapsing a region of the lung, adhering one portion of the...
|
|
WO2000072857A9 |
In accordance with the present invention a novel fibrin polymer structure is disclosed. The novel fibrin polymer structure useful, for example, as a surgical sealant, is comprised of a plurality of discrete, droplets of polymerizing or p...
|
|
WO/2002/046240A1 |
A method of preparing multicomponent salts of a compound in aqueous solution includes the steps of first selecting at least a weak acid, then selecting at least a first weak base, mixing an equivalent mole amount of the weak acid with th...
|
|
WO/2002/043743A1 |
Methods of enhancing the photostabilizing of silver in medical materials are described. More particularly, the methods increase the photostabilization of silver in certain materials comprising hydrophilic, amphoteric and anionic polymers...
|
|
WO/2002/040072A2 |
The present invention relates to a filler composition for soft-tissue augmentation and reconstructive surgery comprising an effective amount of an injectable thermo-gelling solution comprising 0.1 to 5.0 % by weight of chitosan or collag...
|
|
WO/2002/036054A1 |
This invention is an anti-proliferative drug placed onto or within a sterile sheet or mesh (10) that is designed to be placed between internal body tissues to prevent the formation of post-operative adhesions, which adhesions are really ...
|
|
WO/2002/030482A1 |
An areal implant has a flexible basic structure on a polymer basis (1) and ultrasonically detectable elements (2) which contain or produce gas and which are set up for detectability for at least four weeks after implantation. The implant...
|
|
WO/2002/030479A1 |
A material for the enhancement of blood coagulation. The material comprises calcium cations, an inorganic oxide, a clay, an inorganic oxide in combination with calcium cations, a zeolite in combination with calcium cations, a zeolite in ...
|
|
WO/2002/026278A2 |
An improved skin-protecting film-forming composition uses the polymer cycloalkyl methacrylate copolymer. In general, a composition according to the present invention comprises: cycloalkyl methacrylate copolymer; an evaporative solvent co...
|
|
WO/2002/026039A1 |
A stabilised composition having antibacterial, antiviral and/or antifungal activity, said composition comprising silver ions and a ligand, characterised in that the composition comprises a complex of silver and a ligand selected from the...
|
|
WO/2002/026845A1 |
The invention relates to an aqueous polymer dispersion produced by free-radical addition polymerisation of vinyl acetate in the presence of at least one ionic emulsifier, at least one radical initiator and at least one protective colloid...
|
|
WO/2002/024150A2 |
The method and device of the present invention for wound treatment includes a transducer (7) to produce waves, preferably ultrasonic waves. The transducer has tip with the distal end (radiation surface). A liquid is directed to the radia...
|
|
WO/2002/024114A2 |
The invention relates to anastomosis stents and plugs comprised of a non-polyglycolic acid material that is resorbable by the patient in about a few minutes up to about 90 days. Such stents and plugs may be employed in surgical technique...
|
|
WO2000062833A9 |
The invention provides a cellular matrix system which comprises cells disposed on microcarrier particles, and an in vitro defined matrix having the microcarrier particles disposed therein. The invention further provides a method for dete...
|
|
WO/2002/022182A1 |
Aqueous gel type preparations for coating a wound having a gel strength in water of from 7.5 to 100 g. These preparations have an effect of promoting wound healing and sufficient water absorption properties for exudates. Moreover, these ...
|
|
WO/2002/018433A1 |
An adhesive protein, present inter alia in the stickleback nest building glue has now been isolated and purified. Its amino acid sequence and correspoinding coding polynucleotide sequences are isolated and sequenced. The protein finds bo...
|
|
WO/2002/016443A1 |
Provided is a composition comprising a pre-formed, hydrolytically susceptible non-addition polyanionic polymer comprising polymer strands formed from at least one ethylenically unsaturated monomer and linking the polymer strands by at le...
|
|
WO2001041776B1 |
The present invention is directed to the use of honey in medical dressings. Preferred embodiments modify honey with a viscosity increasing agent, resulting in a range of possible compositions including ointments and salves, self-adhesive...
|
|
WO/2002/015913A1 |
Provided is a method of treating an area affected by a trauma, such as a corneal wound or internal trauma, comprising administering to the affected area a trauma treating effective amount of a composition comprising a polyanionic polymer.
|
|
WO/2002/009765A1 |
Disclosed are methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss. Specifically, the methods of this invention involve the in situ formation of a polymeric cyanoacrylate film at the sit...
|
|
WO/2002/005753A1 |
The invention concerns a hydrogel of at least a polymer selected among proteins, polysaccharides and derivatives thereof. The invention is characterised in that the sterile hydrogel contains said crosslinked polymer as well as an efficie...
|
|
WO2001043787B1 |
A process is disclosed for preparing an autologous platelet gel and membranes thereof comprising mixing a platelet concentrate with a calcium salt and batroxobin. This process encompassing the use of batroxobin as the gel activator allow...
|
|
WO/2002/000244A2 |
A protein mixture that is useful in the treatment of wounds, where the mixture is isolated from bone or is produced from recombinant proteins and may include two or more of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, BMP-7, TGF-$g(b)1, TGF-$g(b)2...
|
|
WO/2002/000269A1 |
A method of manufacturing a dressing (1) which incorporates a honey composition (7) and a base material (2) is disclosed. The method includes the steps of preparing the honey composition (7) and of the base material (2), characterised by...
|
|
WO/2002/000268A1 |
A composition for the treatment of wound or skin injury which is in sprayable form prior to application to the wound and comprises from 0.25 % to 1.5 % by weight of the composition of a gellan gum the viscosity of said composition increa...
|
|
WO/2001/097826A2 |
A hemostatic composition which comprises at least one procoagulant metal ion, such as silver (I) or mercury (II), and at least one procoagulant biopolymer, such as collagen, thrombin, prothrombin, fibrin, fibrinogen, heparinase, Factor V...
|
|
WO/2001/097873A2 |
Subject of the invention is a collagen hemostat based on liquid collagen of neutral pH and of low density. Its specific weight is in the range of 0.07 to 0.9 mg/cm?3¿. The hemostat according to the invention preferably contains additive...
|
|
WO/2001/096422A1 |
The present invention provides a process for the manufacture of a high water content (greater than about 40 % by weight of water) cross-linked hydrogel composition which has an acceptable non-greasy 'feel', sufficient structural integrit...
|
|
WO/2001/093857A1 |
The present invention is directed to a composition for treating burns. The composition comprises a therapeutically effective amount of one or more weak organic acid compatible with human skin, in a pharmacologically effective carrier del...
|
|
WO/2001/091774A2 |
The invention provides a method of treating a chronic ulcer, such as a diabetic ulcer, comprising administering a therapeutic amount of a hydrogen matrix to the ulcer, the matrix composition comprising gelatin and a long chain carbohydra...
|
|
WO/2001/091773A2 |
The invention provides a method of stimulating hair growth, comprising administering a therapeutic amount of a hydrogel matrix to an intradermal or subdermal site where hair growth is desired, the matrix composition comprising gelatin, s...
|
|
WO/2001/091682A1 |
A polymerized hydroge composition and applicator for hydrating or dehydrating a surface, particularly a dermatological surface, to which it is applied and a method for forming the composition. The composition is comprised of a mixture of...
|
|
WO/2001/090252A1 |
A gelling composition which comprises a polymeric ingredient and a gellant for causing the polymeric ingredient to gel and which undergoes at least two kinds of gelation, i.e., relatively fast gelation F and relatively slow gelation S. T...
|
|
WO/2001/089593A1 |
The present invention relates to a method of preparing a composition for wound healing, and for repairing and regenerating human and animal tissue, said method comprising the following steps: a) providing a plasmid DNA in substantially p...
|
|
WO/2001/089464A1 |
The invention relates to antiperspirant/deodorant soft solid compositions which comprise: a) a volatile silicone or a volatile hydrocarbon compound; b) a structuring wax; c) a silicone elastomer at from 0.1 to 30 %; and d) an antiperspir...
|
|
WO/2001/085184A2 |
A protectant composition comprising vernix for a skin curative and skin protectant effect and a method of using the composition. A natural or synthetic vernix is dispersed in an effect amount and is applied to a surface. The method may b...
|
|
WO/2001/081437A1 |
Compositions having a curable unsaturated compound, an adhesion promoter and curing agent which have a peak exotherm of less than 50 °C are disclosed. The compositions when cured are flexible bioadhesives which are also disclosed. Non-c...
|
|
WO/2001/077422A1 |
The present invention relates to a process for the production of fibres of an unhydroxylated recombinant collagen polypeptide, and the fibres obtained thereby, as well as to uses of such fibres as a biomaterial.
|
|
WO/2001/076650A1 |
The present invention provides methods and compositions for promoting wound healing and reducing scar formation. In particular, the present invention provides cyanoacrylate polymer sealants formulated to contain biologically active eleme...
|
|
WO2000050016A9 |
The present invention provides compositions and methods for improving the integrity of body passageways following surgery or injury. Representative examples of therapeutic agents include microtubule stabilizing agents, fibrosis inducers,...
|
|
WO/2001/070288A2 |
A temperature-sensitive polymer formulation for delivery of osteoinductive proteins is disclosed. The formulation comprises a pharmaceutically acceptable admixture of a temperature sensitive polymer and an osteoinductive protein. The for...
|
|
WO/2001/068079A2 |
Disclosed are viscoelastic compositions and methods of their use in surgical and non-surgical packing and in effecting drug delivery, especially in conjunction with trauma to or disorders of the ear.
|
|
WO/2001/067888A1 |
This invention is directed to methods of manufacture, apparatus for manufacturing and final products produced in accordance with a honey based product. The product is produced by combining a quantity of thickening agent with a solvent to...
|
|
WO/2001/062312A1 |
This invention relates generally to a foamed-wound dressing containing albumin and at least one other protein. The foam dressing is prepared initially as a liquid composition, but forms a foam when a shear force is applied to the liquid....
|
|
WO/2001/059137A1 |
Methods for providing transgenic plants and parts hereof that, relative to the wild type state, is modified in a complex cell wall polysaccharide structure including pectins and hemicelluloses, the modification being in the overall glyco...
|
|
WO/2001/056475A1 |
There are described devices implantable in the human or animal body. Such a device takes the form of a pre-formed three-dimensional article, comprising at least in part a material which is hydratable and capable of bonding to tissue whil...
|
|
WO/2001/056595A2 |
The present invention provides compositions and methods for promoting wound healing. The composition comprises virgin monomers of tropoelastin and lysyl oxidase. When the lysyl oxidase comes in contact with the tropoelastin, cross-linkin...
|
